Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
March 24, 2006
Integrin receptor activation triggers converging regulation of Cav1.2 calcium channels by c-Src and protein kinase A pathways
Peichun Gui, Xin Wu, Shizhang Ling, et al.
Glia
|
June 30, 2015
Axo-glial communication through neurexin-neuroligin signaling regulates myelination and oligodendrocyte differentiation
Dustin T Proctor, Stephanie C Stotz, Lucas O M Scott, et al.
Molecular Brain
|
June 3, 2014
Inorganic polyphosphate regulates neuronal excitability through modulation of voltage-gated channels
Stephanie C Stotz, Lucas Om Scott, Christopher Drummond-Main, et al.
Pharmacology Research & Perspectives
|
April 13, 2022
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy
Li Fu, Sylwia Wasiak, Laura M Tsujikawa, et al.
Kidney International Reports
|
June 2, 2018
Benefit of Apabetalone on Plasma Proteins in Renal Disease
Sylwia Wasiak, Laura M Tsujikawa, Christopher Halliday, et al.
International Immunopharmacology
|
March 1, 2023
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Li Fu, Dean Gilham, Stephanie C Stotz, et al.
Atherosclerosis
|
November 27, 2018
Apabetalone downregulates factors and pathways associated with vascular calcification
Dean Gilham, Laura M Tsujikawa, Christopher D Sarsons, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 10, 2022
Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators
Laura M Tsujikawa, Olesya A Kharenko, Stephanie C Stotz, et al.
Cardiovascular Therapeutics
|
August 22, 2020
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response <i>In Vitro</i>, in Mice and in Patients with Cardiovascular Disease
Sylwia Wasiak, Dean Gilham, Emily Daze, et al.
Biomedicines
|
April 30, 2021
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
Dean Gilham, Audrey L Smith, Li Fu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
March 24, 2006
Integrin receptor activation triggers converging regulation of Cav1.2 calcium channels by c-Src and protein kinase A pathways
Peichun Gui, Xin Wu, Shizhang Ling, et al.
Glia
|
June 30, 2015
Axo-glial communication through neurexin-neuroligin signaling regulates myelination and oligodendrocyte differentiation
Dustin T Proctor, Stephanie C Stotz, Lucas O M Scott, et al.
Molecular Brain
|
June 3, 2014
Inorganic polyphosphate regulates neuronal excitability through modulation of voltage-gated channels
Stephanie C Stotz, Lucas Om Scott, Christopher Drummond-Main, et al.
Pharmacology Research & Perspectives
|
April 13, 2022
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy
Li Fu, Sylwia Wasiak, Laura M Tsujikawa, et al.
Kidney International Reports
|
June 2, 2018
Benefit of Apabetalone on Plasma Proteins in Renal Disease
Sylwia Wasiak, Laura M Tsujikawa, Christopher Halliday, et al.
International Immunopharmacology
|
March 1, 2023
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Li Fu, Dean Gilham, Stephanie C Stotz, et al.
Atherosclerosis
|
November 27, 2018
Apabetalone downregulates factors and pathways associated with vascular calcification
Dean Gilham, Laura M Tsujikawa, Christopher D Sarsons, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 10, 2022
Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators
Laura M Tsujikawa, Olesya A Kharenko, Stephanie C Stotz, et al.
Cardiovascular Therapeutics
|
August 22, 2020
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response <i>In Vitro</i>, in Mice and in Patients with Cardiovascular Disease
Sylwia Wasiak, Dean Gilham, Emily Daze, et al.
Biomedicines
|
April 30, 2021
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
Dean Gilham, Audrey L Smith, Li Fu, et al.
Page
of 3